1,371 Shares in The Clorox Company (NYSE:CLX) Purchased by Stanley Laman Group Ltd.

Stanley Laman Group Ltd. acquired a new position in shares of The Clorox Company (NYSE:CLXFree Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,371 shares of the company’s stock, valued at approximately $202,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLX. Redwood Park Advisors LLC bought a new stake in shares of Clorox during the fourth quarter valued at approximately $26,000. Millstone Evans Group LLC bought a new position in Clorox in the 4th quarter worth approximately $31,000. Wood Tarver Financial Group LLC bought a new position in Clorox in the 4th quarter worth approximately $31,000. Asset Planning Inc bought a new position in Clorox in the 4th quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. bought a new position in Clorox in the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CLX. Evercore ISI set a $140.00 price objective on Clorox and gave the stock an “underperform” rating in a report on Tuesday, May 6th. JPMorgan Chase & Co. decreased their price objective on Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company decreased their price objective on Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. UBS Group decreased their price objective on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Finally, Barclays decreased their price objective on Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $151.23.

Check Out Our Latest Report on Clorox

Clorox Stock Performance

Shares of NYSE CLX opened at $123.03 on Friday. The Clorox Company has a 1 year low of $122.84 and a 1 year high of $171.37. The stock has a fifty day moving average price of $134.91 and a two-hundred day moving average price of $148.48. The firm has a market cap of $15.16 billion, a P/E ratio of 33.61, a PEG ratio of 2.62 and a beta of 0.54. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the company posted $1.71 EPS. Clorox’s revenue was down 8.0% on a year-over-year basis. Research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Activity

In related news, Director Pierre R. Breber acquired 4,000 shares of the business’s stock in a transaction dated Wednesday, May 7th. The stock was bought at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now owns 4,000 shares of the company’s stock, valued at approximately $546,280. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.